Perspective Therapeutics (CATX) had the highest return in Q4 2005 by a US stock, returning 1,318,081.8%.
| ASSET | QUARTER | % RETURN |
|---|---|---|
Perspective Therapeutics (CATX) | Q4 2005 | 1,318,081.82% |
NanoViricides (NNVC) | Q4 2005 | 45,810.1% |
Theriva Biologics (TOVX) | Q4 2005 | 4,275.02% |
Protalix Biotherapeutics (PLX) | Q4 2005 | 1,923.81% |
Universal Insurance (UVE) | Q4 2005 | 1,444.05% |
Hirequest (HQI) | Q4 2005 | 511.54% |
Air Industries (AIRI) | Q4 2005 | 237.94% |
Widepoint C (WYY) | Q4 2005 | 173.17% |
Gran Tierra Energy (GTE) | Q4 2005 | 162.86% |
Champions Oncology (CSBR) | Q4 2005 | 150% |
Tanzanian Royalty Exploration (TRX) | Q4 2005 | 141.83% |
Silicom (SILC) | Q4 2005 | 128.5% |
Dominari (DOMH) | Q4 2005 | 126.97% |
Heritage Global (HGBL) | Q4 2005 | 117.86% |
US Global Investors (GROW) | Q4 2005 | 107.47% |
Novavax (NVAX) | Q4 2005 | 105.88% |
OLB (OLB) | Q4 2005 | 100% |
PEDEVCO (PED) | Q4 2005 | 100% |
Lisata Therapeutics (LSTA) | Q4 2005 | 100% |
Citi Trends (CTRN) | Q4 2005 | 97% |
Mitek Systems (MITK) | Q4 2005 | 96.25% |
Sify Technologies (SIFY) | Q4 2005 | 94.93% |
Asure Software (ASUR) | Q4 2005 | 91.18% |
Hurco Companies (HURC) | Q4 2005 | 87.13% |
GeoVax Labs (GOVX) | Q4 2005 | 80.95% |
